PQ 439
439. Deputy Marc MacSharry asked the Minister for Health the role the US Food and Drug Administration, FDA, has in assessing a medicine for reimbursement here under the Health (Pricing and Supply of Medical Goods) Act 2013; if a conflicting position between the FDA and the European Medicines Authority has a material role in assessing such medicines; and if he will make a statement on the matter. [42316/17]
Introduced
10 October 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
10 October 2017
Summary
439. Deputy Marc MacSharry asked the Minister for Health the role the US Food and Drug Administration, FDA, has in assessing a medicine for reimbursement here under the Health (Pricing and Supply of Medical Goods) Act 2013; if a conflicting position between the FDA and the European Medicines Authority has a material role in assessing such medicines; and if he will make a statement on the matter. [42316/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 10 October 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-10-10/439/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-10-10/pq_439